Association of a structural variant within the SQSTM1 gene with amyotrophic lateral sclerosis. (April 2020)

• Record Type: Journal Article
• Authors: Pytte, Julia; Anderton, Ryan S.; Flynn, Loren L.; Theunissen, Frances; Jiang, Leanne; Pitout, Ianthe; James, Ian; Mastaglia, Frank L.; Saunders, Ann M.; Bedlack, Richard; Siddique, Teepu; Siddique, Nailah; Akkari, P. Anthony
• Is Part Of: Neurology. Volume 6:Number 2(2020)
• Publication Date: 2020-04
• Subjects: Neurogenetics -- Periodicals; 616.80442
• DOI: 10.1212/NXG.0000000000000406
• Languages: English
• ISSNs: 2376-7839

Abstract

Abstract : Objective: As structural variations may underpin susceptibility to complex neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), the objective of this study was to investigate a structural variant (SV) within sequestosome 1 ( SQSTM1 ). Methods: A candidate insertion/deletion variant within intron 5 of the SQSTM1 gene was identified using a previously established SV evaluation algorithm and chosen according to its subsequent theoretical effect on gene expression. The variant was systematically assessed through PCR, polyacrylamide gel fractionation, Sanger sequencing, and reverse transcriptase PCR. Results: A reliable and robust assay confirmed the polymorphic nature of this variant and that the variant may influence SQSTM1 transcript levels. In a North American cohort of patients with familial ALS (fALS) and sporadic ALS (sALS) (n = 403) and age-matched healthy controls (n = 562), we subsequently showed that the SQSTM1 variant is associated with fALS ( p = 0.0036), particularly in familial superoxide dismutase 1 mutation positive patients ( p = 0.0005), but not with patients with sALS ( p = 0.97). Conclusions: This disease association highlights the importance and implications of further investigation into SVs that may provide new targets for cohort stratification and therapeutic development.